Japanese Price Revision Debate Will Address 10 Product Categories
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will oppose foreign average price (FAP) revisions to PTCA catheters in arguments before Japan's Ministry of Health, Labor & Welfare Chuikyo advisory panel Jan. 15